National experts point to key developments in rheumatology to watch in the coming year.
Abatacept Treatment May Slow Atherosclerosis Progression
2024 State of the Air: Record Highs in US Particle Pollution, with John Balmes, MD
Proposed Golimumab Biosimilar AVT05 Meets Primary Endpoints in Moderate to Severe RA
Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations
Sleep of Psoriasis Patients Improves with Intensive Topical Treatment
Guselkumab, Risankizumab Boast Longest Drug Survival Among IL-17, IL-23 Inhibitors